Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The diphosphonate was the most effective at preventing calcification in rats.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

A new compound effectively inhibits human 5α-reductase 1.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

New compounds may help treat prostate issues without affecting androgen receptors.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Compound 4 is a promising treatment for hair loss with low toxicity.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Dutasteride may help reduce brain inflammation and improve cognition.

Finasteride reduces movement issues in Parkinson's disease rats.